To validate the therapeutic relevance of KLF4 in breast cancer DNA repair/DNA damage targeting treatment, we have conducted an in vivo mouse xenograft study by using murine 4T1 model, which harbors wild‐type BRCA1 expression (Castle et al, 2014). This evidence concerns the gene BRCA1 and breast cancer.